Log in
Enquire now
‌

US Patent 9034892 Forms of rifaximin and uses thereof

Patent 9034892 was granted and assigned to Salix Pharmaceuticals on May, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

The present invention relates to Rifaximin polymorphic, salt, hydrate, and amorphous forms, to their use in medicinal preparations and to therapeutic methods using them.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9034892 Forms of rifaximin and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo